Le Lézard
Classified in: Health, Science and technology
Subject: IMA

Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse


TOKYO, Dec. 8, 2021 /PRNewswire/ -- Nippon Express (Nederland) B.V. (hereinafter "NEN"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification, effective September 6, for its company-owned warehouse in Schiphol Trade Park near Amsterdam's Schiphol Airport, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.

Logo: https://kyodonewsprwire.jp/img/202112014248-O2-DvOj4uIB

Photo1: Warehouse exterior
https://kyodonewsprwire.jp/prwfile/release/M103866/202112014248/_prw_PI1fl_Lv4vEAOc.jpg

Photo2: Warehouse interior
https://kyodonewsprwire.jp/prwfile/release/M103866/202112014248/_prw_PI3fl_78SFb5Xi.jpg

The Netherlands has become home to one of Europe's largest clusters of cutting-edge biotechnology companies, and the country's geographical and tax advantages have encouraged numerous pharmaceutical manufacturers to set up logistics bases there.

NEN's warehouse near Schiphol Airport, an import/export gateway for Europe, is fully equipped with dedicated pharmaceutical storage areas boasting temperature-control functions for three temperature ranges -- 15 C to 25 C (constant-temperature storage), 2 C to 8 C (refrigerated storage) and -15 C to -25 C (frozen storage) -- as well as dedicated truck docks, enabling NEN to enhance its pharmaceutical transport services to meet anticipated increases in demand.

Nippon Express remains committed to improving its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers, and the Company will continue to strengthen its efforts on behalf of the pharmaceutical industry, identified as a priority industry in its Medium-term Business Plan.

Profile of facility
Name: Nippon Express (Nederland) B.V. Schiphol Airport Logistics Centre
Address: Contour Avenue 31, 2133 LD Hoofddorp, The Netherlands

Nippon Express website: http://www.nipponexpress.com/

Official LinkedIn account: NIPPON EXPRESS GROUP
https://www.linkedin.com/company/nippon-express-group/

SOURCE Nippon Express Co., Ltd.


These press releases may also interest you

at 16:20
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 330,000 shares of common stock. Awards were made to six new employees of the Company. The...

at 16:15
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
eHealth, Inc. , a leading private online health insurance marketplace (the "Company"), today announced that on July 1, 2024, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an...

at 16:10
bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)
bluebird bio, Inc. today announced that the Compensation Committee of the Company's Board of Directors approved an inducement grant of stock options to purchase a total of 300,000 shares of common stock to its chief financial officer, James...

at 16:10
Consumer Healthcare Market size is set to grow by USD 170.2 billion from 2024-2028, Awareness about lifestyle diseases boost the market, Technavio
The global consumer healthcare market size is estimated to grow by USD 170.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Awareness about lifestyle diseases is driving...

at 16:05
Voomtm Medical Devices' Revcontm Anchor Single Screwtm Named First on Podiatry Today's 2024 Top 10 Innovations
Voomtm Medical Devices, Inc. ("Voom"), the orthopedic medical device company behind the disruptive, game-changing Revcontm bunion screw technology, is honored to be named first on Podiatry Today's 2024 Top 10 Innovations list. Voom's one-of-a-kind...

at 16:05
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to four new employees. The Compensation...

More news about Health...


News published on and distributed by: